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antivirus defense systems in prokaryotes
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convergence
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Abstract: Complementarity between nucleic acid molecules is central to biological information transfer processes.
Apart from the basal processes of replication, transcription and translation, complementarity is also employed by
multiple defense and regulatory systems. All cellular life forms possess defense systems against viruses and mobile
genetic elements, and in most of them some of the defense mechanisms involve small guide RNAs or DNAs that
recognize parasite genomes and trigger their inactivation. The nucleic acid-guided defense systems include prokaryotic
Argonaute (pAgo)-centered innate immunity and CRISPR-Cas adaptive immunity as well as diverse branches of RNA
interference (RNAi) in eukaryotes. The archaeal pAgo machinery is the direct ancestor of eukaryotic RNAi that, however,
acquired additional components, such as Dicer, and enormously diversified through multiple duplications. In contrast,
eukaryotes lack any heritage of the CRISPR-Cas systems, conceivably, due to the cellular toxicity of some Cas proteins
that would get activated as a result of operon disruption in eukaryotes. The adaptive immunity function in eukaryotes
is taken over partly by the PIWI RNA branch of RNAi and partly by protein-based immunity. In this review,
I briefly discuss the interplay between homology and analogy in the evolution of RNA- and DNA-guided immunity,
and attempt to formulate some general evolutionary principles for this ancient class of defense systems.
Reviewers: This article was reviewed by Mikhail Gelfand and Bojan Zagrovic.
Background
Replication of digital information carriers, specifically
nucleic acids, is the central, distinguishing feature of life
[1–3]. Only with the onset of replication with sufficient
fidelity to ensure information transmission across genera-
tions, evolution by natural selection and drift can take off
[4, 5]. An intrinsic feature of even the simplest evolving
replicator systems is the emergence and persistence of para-
sitic genetic elements [6–8]. Since that earliest stage of
evolution, the entire subsequent history of life was a story
of host-parasite coevolution, given that, in the long run,
hosts cannot purge parasites, primarily because this would
require a drop in the horizontal gene transfer rate that
would be incompatible with evolutionary stability [8–11].
Strikingly, in today’s biosphere, the most abundant entities
are not cells but viruses: the counts of virus particles exceed
cell counts by one to two orders of magnitude in most
environments [12–16]. An equally striking, complementary
fact established by comparative genomics is that the
genomes of many eukaryotes, particularly complex multi-
cellular forms such as mammals or flowering plants, consist
mostly of sequences derived from mobile genetic elements
(MGE) [17, 18]. Given the inevitability of genetic parasites,
evolution of defense systems by the cellular hosts and their
diversification in the course of the perennial host-parasite
arms race is one of the central aspects in the evolu-
tion of life.
The nucleic acid complementarity is the foundation of
genomic replication, and hence a first principle of life.
Thus, conceptually, it appears natural that an anti-parasite
defense system would employ that same principle to
recognize parasitic nucleic acids and target them for
destruction by dedicated devices such as nucleases [19]. A
defense system of this type would consist of a specificity
component, a nucleic acid molecule of the optimal size
for the recognition of a family of parasites, while avoiding
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self-recognition (hereinafter denoted the guide), and an
operational (catalytic) component that is responsible for
the efficient cleavage of the parasite genome (Fig. 1). In
the extant defense systems, the catalytic function is allot-
ted to dedicated protein enzymes but it stands to reason
that in the primordial RNA world, the guide itself could
be a ribozyme endowed with nuclease activity (Fig. 1).
The guide-dependent defense systems are indeed nearly
ubiquitous among cellular organisms. In archaea and bac-
teria (hereinafter, collectively denoted prokaryotes), these
include the recently discovered but common mechanisms
of innate immunity centered around the prokaryotic
Argonaute (pAgo) family nucleases [20] and the CRISPR-
Cas systems which represent adaptive immunity [21–24].
Eukaryotes possess the enormously diversified network of
RNA interference (RNAi) pathways, which include pri-
marily innate immunity mechanisms, albeit in some cases,
endowed with epigenetic immune memory (i.e. carry over
of small interfering RNAs across generations), as well as a
distinct type of adaptive immunity, the piwiRNA
mechanism [19, 25–29]. Furthermore, in eukaryotes,
the guide-dependent defense systems have expansively
branched into mechanisms of gene expression regula-
tion, and to a lesser extent, this trend is observed in
prokaryotes as well.
Comparative genomic analysis has provided considerable
insights into the origin and evolution of nucleic acid-guided
defense systems. The relationships between prokaryotic and
eukaryotic defense mechanisms are complicated and com-
bine homology with functional analogy. In this article, with-
out going in detail into the diversity of the eukaryotic RNAi
systems, I present an overview of the evolutionary scenarios
for the nucleic acid-guided defense and discuss the likely
evolutionary forces behind the proliferation of the
Ago-based mechanisms and the surprising demise of
CRISPR-Cas in eukaryotes.
The long journey of the Argonautes: direct inheritance of
the prokaryotic guide-dependent innate immunity by
eukaryotes
The Argonaute (AGO) genes were initially identified for
their roles in plant development [30, 31]. The unusual
name was coined because the AGO1 knockouts of Arabi-
sopsis thaliana showed a peculiar leave shape, supposedly
resembling a squid (Argonautes are not squids but a
distinct, ancient branch of octopuses; the name seems to
have been chosen for the sake of euphony) [30]. The sub-
sequent developments around the Argonautes certainly
beg changing the metaphor: this protein family has
delivered the Golden Fleece. The first function of Ago
characterized at the molecular level was the role of
“slicer” in the eukaryotic siRNA response, i.e. the
RNase that cleaves the target RNA base-paired with a
small interfering (si)RNA [32–34]. Shortly thereafter, it
has been established that enzymatically inactive mem-
bers of the Ago family complexed with micro(mi)RNAs
Fig. 1 The evolutionary history of eukaryotic RNAi: assembly from diverse archaeal and bacterial ancestors. The “bacterial” and “archaeal” components
of the RNAi protein machinery are assumed to have evolved from the proto-mitochondrial endosymbiont and its archaeal host, respectively.
This scenario rests on the fact that RNase III is a protein that is nearly ubiquitous in bacteria but rare in archaea, and the (DNA-dependent)
RNA polymerase that is thought to be the ancestor of the RNAi RdRp so far has been identified only in bacteriophages (not in archaeal viruses). However,
it cannot be ruled out that these genes have been acquired by the mesophilic archaeal ancestor of eukaryotes (presumably, a member
of the Lokiarchaeota) prior to endosymbiosis. RIII, RNAse III
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reversibly suppress the translation of the target mRNAs
instead of cleaving them [35, 36].
The catalytically active moiety of the Ago proteins is the
RNase H domain, one of the most common, versatile nu-
cleases in cellular organisms and viruses that additionally
adopted the ATPase activity in the nearly ubiquitous
HSP70 family of molecular chaperones [37]. The distinct
variety of the RNase H domain represented in Ago is
known as the PIWI domain, after P element–Induced
WImpy testis, a Drosophila mutant [38]. The RNase H
domain encompasses the DED[DHK] tetrad of amino acid
residues essential for catalysis which coordinate two
divalent cations and catalyze RNA hydrolysis through
a mechanism that is shared by a great variety of
nucleic acid processing enzyme, not only nucleases
but also polymerases.
Argonautes are large proteins of about 800–1200 amino
acids that, in addition to the catalytic PIWI domain,
contain non-catalytic domains, known as the PAZ (PIWI-
Argonaute-Zwille), MID (Middle) and N domain, along
with two domain linkers, L1 and L2 [20, 38–40] (Fig. 1).
The MID domain is essential for binding the 5′-end of the
guide and is present in all Ago proteins. The PAZ domain,
which contains an OB-fold core typical of diverse nucleic
acid-binding proteins, is not essential for the guide
binding but stabilizes the guide from the 3’end. The N
domain is not required for the guide loading but sub-
stantially contributes to the dissociation of the second,
passenger strand of the loaded dsRNA and to the target
cleavage. As discussed below, only the PIWI and MID
domain are present throughout the Ago family whereas
the PAZ and N domains are missing in some family
members (Fig. 1).
Although initially Argonautes have been described as
highly conserved eukaryote-specific proteins [30, 41],
prokaryotic homologs of eukaryotic Ago (hereinafter,
pAgo and eAgo, respectively) soon have been discovered
in many bacteria and archaea. The spread of pAgo is
limited, however, with about one third of the archaeal
genomes and about 10% of the bacterial genomes shown
to encode a member of this family [20]. The structures
of several pAgo proteins have been solved, establishing
the identities of the PIWI, PAZ and MID domain and
unexpectedly demonstrating that at least some pAgos
preferentially bind guide DNA rather than RNA mole-
cules [42, 43]. These observations notwithstanding, the
biological functions of pAgo have remained obscure.
However, comparative analysis of the genomic neighbor-
hoods of the pAgo genes has strongly suggested a role in
defense [44]. Indeed, many of the pAgo genes are embed-
ded in ‘defense islands’, the regions of bacterial and
archaeal genomes that are significantly enriched for genes
involved in various defense functions. Furthermore, even
more tellingly, genes encoding pAgo variants with
inactivated PIWI domains are often adjacent to genes
encoding other nucleases, leading to the obvious hy-
pothesis that these enzymatically inactive pAgos en-
sure the recognition of targets that are then cleaved by
the associated active nucleases.
The hypothesis on the defense function of pAgo has
been experimentally tested, with striking results, although
the scope of the experiments remains limited. The ability
to cleave target nucleic acids in vitro has been demon-
strated for pAgos from the bacteria Aquifex aeolicus [42]
and Thermus thermophilus [45], and the archaea Metha-
nocaldococcus jannaschii [46] and Pyrococcus furiosus
[47]. Notably, all three catalytically active pAgos employ
ssDNA guides but differ in their ability to cleave RNA or
DNA. In contrast, no nuclease activity has been dem-
onstrated for the RNA-binding pAgo of the bacterium
Rhodobacter sphaeroides that has been predicted to be
inactive due to mutations in the catalytic center of the
PIWI domain [48].
The defense functions have been demonstrated for the
pAgo from R. spheroides [48] and T. thermophilus [49].
The T. thermophilus Ago restricts plasmid replication by
cleaving the plasmid DNA using plasmid-derived small
ssDNA guides. The mechanism of the guide generation
is not understood in detail but it has been shown that
the catalytic residues of the PIWI domain are required
[49]. Accordingly, it appears likely that pAgo first shreds
the plasmid DNA in a guide- (and presumably, sequence)
independent manner and then becomes a target-specific
nuclease after acquiring the guides. What determines the
self/non-self discrimination at the first stage, remains un-
clear. For the R. spheroides pAgo, association with short
RNAs that represent much of the bacterial transcriptome
has been demonstrated [48]. In addition, this Ago is asso-
ciated with ssDNA molecules complementary to the small
RNAs, and this DNA population is enriched in “foreign”
sequences, those from plasmids as well as mobile
elements integrated into the bacterial chromosome.
Apparently, in R. sphaeroides, pAgo samples degrad-
ation products of the bacterial transcriptome and then,
via yet unknown mechanisms, preferentially generates
complementary DNAs for foreign sequences that are
used to repress the expression of the cognate elements.
Whether or not the function of this catalytically
inactive pAgo requires other nucleases, remains to be
determined. Nevertheless, the presence of pAgo within
evolutionarily conserved operons with genes for nucleases
and helicases [20, 44] implies complex organization of the
prokaryotic Ago-centered defense systems that remains to
be investigated. Such experiments should clarify the
mechanisms employed by the prokaryotic pAgo-centered
defense systems to generate the guide RNA and DNA
molecules and discriminate the genomes of parasites from
those of the hosts.
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Unlike the prokaryotic counterparts, the eukaryotic
Ago-centered molecular machinery that is involved in
RNAi has been studied in great detail. The diversity of the
eukaryotic Ago family is staggering and involves multiple
catalytically active (slicers) as well as even more numerous
inactivated forms [50–53]. In addition to the defense func-
tion in the form of the small interfering (si) RNA branch
of RNAi, eukaryotes possess a variety of regulatory path-
ways in the micro(mi)RNA branch [54–57]. Typically, the
defense function of RNAi includes cleavage of foreign
(virus) dsRNAs by active eAgo, whereas the miRNA path-
ways involve binding and reversible inactivation of mRNA,
not involving cleavage, by inactive eAgo varieties (al-
though in some cases, degradation of the mRNA by other
nucleases is promoted). The antivirus and regulatory
branches of RNAi appear to be directly linked: viral infec-
tion induces the formation of endogenous siRNA thst
silence numerous host genes [58].
The structural and functional diversity as well as the
details of evolution of eukaryotic RNAi are discussed in
numerous reviews [59–61] and are not our primary con-
cern here. Instead, we specifically focus on the prokaryotic
roots of the eukaryotic RNAi (Fig. 1). In addition to eAgo,
the second major protein that is involved in all RNAi
pathways is Dicer which is responsible for the generation
of siRNA from viral dsRNA and miRNA from precursor
RNA molecules containing long double-stranded regions
[62–65]. Similarly to eAgo, the Dicers form an extensive
family of paralogs with distinct functions in various
branches of RNAi [66–68]. Again, in parallel to Ago, Dicer
is a multidomain protein that consists of a Superfamily II
helicase, two RNase III domains and a Paz domain (Fig. 1)
[69, 70]. Notably, in addition to its function in siRNA
generation from viral dsRNA, Dicer has been shown to
play a direct role in the defense against DNA viruses, such
as adenoviruses, via cleavage of small RNAs that are
involved in virus reproduction [71].
Apart from eAgo and Dicer, the third key protein of
RNAi is a distinct RNA-dependent RNA polymerase
(RdRp) that is involved in the amplification of the siRNA in
most eukaryotes [72, 73]. The RdRp was lost at the onset of
vertebrate evolution and in several other eukaryotic lineages
but clearly is an ancestral component of eukaryotic RNAi
[69]. These three proteins, eAgo, Dicer and RdRp, comprise
the conserved core of RNAi (Fig. 1). The RISCs (RNA-In-
duced Silencing Complexes) include a variety of accessory
proteins but these are not highly conserved in eukaryotic
evolution [38]. Phylogenetic analysis of the Ago superfamily
unequivocally places eAgo within a distinct branch of
archaeal pAgo, namely the euryarchaeal branch. This
specific origin of eAgo is notable in itself, given the recent
identification of the archaeal group that is ancestral to
eukaryotes, the Lokiarchaeota [74, 75]. The currently avail-
able Lokiarchaeum genome does not encode a pAgo
homolog (as confirmed by BLASTP search of the Lokiarch-
aeum proteins using eAgo sequences as queries) suggesting
that the actual archaeal ancestor of the eukaryotes acquired
this gene from a euryarchaeal source, in agreement with
the “mobile eukaryome” scenario [76]. Under this model,
the genes that became eukaryotic signatures are frequently
horizontally transferred in archaea such that the eukaryotic
ancestor accumulated, more or less by chance, the
entire “eukaryome”.
The apparent evolutionary history of Dicer is far more
complicated than that of eAgo [69]. There is no ortholog
of Dicer in either bacteria or archaea but the roots of
individual domains are readily traceable (Fig. 1). RNase
III is present in nearly all bacteria but only in very few
mesophilic archaea that clearly acquired this gene via
HGT [69, 77]. The helicase domain of Dicer comes from
an altogether different line of descent: the closest homologs
belong to the ERCC4 family of archaeal and eukaryotic
helicases that are involved in DNA replication and repair
(Fig. 1). Thus, the helicase moiety of Dicer is ultimately of
euryarchaeal origin, possibly coming from the same source
as eAgo. Finally, the PAZ domain is shared between Dicer
and eAgo suggestive of an ancient recombination event
between the genes encoding these key proteins of RNAi
(Fig. 1). Finally, the distinct RdRp involved in RNAi adopts
the double-psi beta barrel fold shared with the large
subunits of DNA-dependent RNA polymerases (DdRp) and
is most closely related to bacteriophage proteins that have
not been characterized experimentally but are predicted to
function as DdRp [78–80]. Thus, as indicated by the
combined evolutionary evidence for its three key proteins,
the eukaryotic RNAi system has a composite origin, with
archaeal, bacterial and bacteriophages contributions (Fig. 1).
It appears to have assembled from these components at an
early stage of eukaryotic evolution, antedating the last com-
mon ancestor of the extant eukaryotes [69].
The RNAi is generally thought of as an innate immunity
mechanism. However, there are two lines of evidence that
link RNAi with adaptive immunity, blurring the boundaries
between the two types of immunity. The first is epigenetic
inheritance of siRNAs. It has been shown that at least in
the nematode Caenorhabditis elegans, siRNA can be
inherited across many generations, and moreover, that
the duration of this inheritance is actively regulated
[81–83]. The second mechanism with features of
adaptive immunity is the piRNA branch of RNAi that
is involved in transposon silencing in the animal germ
line [84, 85]. The piRNAs are generated by processing
of transcripts of degraded copies of transposons and
loaded onto different Argonautes. The primary piR-
NAs are employed as guides to recognize and silence
integrated transposons by triggering a modification in
histone methylation that cause heterochromatinization.
Notably, the piRNA pathway includes an additional
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regulatory loop, the so-called ping-pong mechanism in
which the primary antisense piRNAs base pair with sense
transcripts that are then cleaved by Ago to generate
secondary, adaptive piRNAs [85].
CRISPR-Cas: evolution of an adaptive immunity system
from mobile genetic elements
The CRISPR-Cas systems became famous thanks to the
enormous utility of some variants for genome editing and
regulation [86, 87]. However, this form of immunity is also
of immense fundamental biological interest, and moreover,
its practical value is a direct consequence of the high speci-
ficity of the RNA-guided immunity mechanism [24]. The
CRISPR-Cas is a bona fide adaptive (acquired) immunity
system with a lasting memory of past infections stored in
the form of unique spacers that are cut out of the target
DNA and inserted between the repeats in a CRISPR array.
The processed transcript of the spacer, the CRISPR (cr)
RNA, is utilized as the guide RNA to recognize and cleave
the target DNA or RNA. The size of the spacers, between
25 and 40 nucleotides, ensures extremely high specificity.
The mechanisms of self/non-self discrimination and even
the actual efficiency of these mechanisms in the case of
CRISPR-Cas remain open problems [88]. The CRISPR-Cas
systems have to discriminate between self and non-self se-
quences on two levels, namely adaptation (spacer selection)
and target recognition. Obviously, recognition of the spacer
itself by the guide crRNA has to be prevented for the
CRISPR-Cas system to be functional. This is achieved via
the Protospacer Adjacent Motif (PAM), a short nucleotide
sequence that is required for the recognition of the cognate
target sequence at both the adaptation and the interference
stages but is absent from the CRISPR themselves [89, 90].
The problem of avoiding spacer acquisition from the host’s
own DNA (and hence autoimmunity) is harder, and
different CRISPR-Cas systems might solve (or ignore)
it differently [91]. For some, strong preference for
DNA that is actively replicated and subject to repair
has been reported, thus biasing adaptation toward
foreign DNA [92]. Others appear to be wasteful, with
virtually no discrimination, resulting in extensive cell
death that, however, is offset by survival of the few
cells that adapt to the infectious agent [93].
The CRISPR-Cas systems demonstrate enormous diver-
sity of gene composition, genomic loci organization and
Cas protein sequences [23]. Nevertheless, extensive com-
parative analysis has revealed major evolutionary trends.
These include multiple key contributions of mobile genetic
elements; serial duplication of cas genes yielding function-
ally versatile effector complexes; and modular organization,
with frequent recombination of the modules [23, 24, 94].
The two modules of the CRISPR-Cas systems include
the suites of genes encoding, respectively, proteins
involved in adaptation and effector functions, i.e. pre-
crRNA processing, and target recognition and cleavage.
Additionally, various proteins involved in ancillary roles
such as regulation of the CRISPR response and probably
CRISPR-associated programmed cell death, can be
assigned to a third, accessory module.
The CRISPR systems are divided into two classes that
differ with respect to the composition and complexity of
the effector modules: multisubunit effector complexes in
Class 1 and single, large effector proteins in Class 2 [23].
The adaptation module is more uniform across the diver-
sity of the CRISPR-Cas systems and consists of the Cas1
and Cas2 proteins although in some CRISPR-Cas variants,
additional proteins, such as the effectors themselves, e.g.
Cas9, and accessory proteins, e.g. Cas4, are also required
for adaptation [91]. Cas1 is the active integrase that cata-
lyzes the protospacer excision from the target DNA and
insertion into the CRISPR array whereas cas2 forms the
structural scaffold of the adaptation complex [95, 96]. Com-
parative genomic analysis has revealed the likely ancestry of
Cas1. Examination of the genomic context of cas1 homo-
logs that are not associated with CRISPR-cas loci led to the
discovery of a novel superfamily of self-synthesizing trans-
posons that have been denoted Casposons because the
Cas1 protein they encode was predicted to function as the
transposase (recombinase) [97, 98]. The integrase activity of
the Casposon-encoded Cas1 subsequently has been
validated experimentally [99], and similar target site
specificities of Casposon integration and CRISPR
spacer incorporation have been demonstrated [100].
Although the currently identified Casposons do not
encode Cas2, some encode Cas4 and additional nucleases
[98]. It seems likely that the entire adaptation module and
perhaps even additional Cas proteins have been donated
by a Casposon [101]. Furthermore, the prototype CRISPR
repeats also could originate from the inverted terminal
repeats of the ancestral Casposon. The ancestry of the ef-
fector module is less clear. Given that Class 1 CRISPR-Cas
are almost universally present in archaea and also com-
mon in bacteria, whereas Class 2 systems are an order of
magnitude less abundant, the multisubunit effector com-
plexes of Class 1 are the most likely ancestral form [102].
Notably, despite the overall high diversity of the Cas pro-
teins, the core subunits of the Class 1 effector complexes
largely consist of multiple variants of the same domain,
the RNA Recognition Motif (RRM) [94]. Some of the
RRM domains possess nuclease activity whereas others
are non-enzymatic RNA-binding proteins. This build-up
of the effector complexes from ultimately homologous,
even if highly diverged, building blocks implies evolution
by gene duplication, with subsequent extensive diversifica-
tion driven by the host-parasite arms race. Conceivably,
the ultimate ancestor of the core Cas proteins could have
been an RRM domain with a nuclease activity, such as
that in the Cas10 protein, that gave rise to the extant
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multitude of active and inactivated versions. Subsequent
evolution of the CRISPR-Cas systems also involved
recruitment of additional proteins such as the helicase-
nuclease Cas3 in the type I systems. What was the func-
tion of the original effector CRISPR-Cas module, before
the fusion with the adaptation module, supposedly
brought about by a Casposon? The previously proposed
possibility is that the effector module evolved from an
ancestral innate immunity system that acquired the adap-
tation capability following the integration of a Casposon
next to the innate immunity locus [101]. So far, however,
innate immunity systems homologous to CRISPR-Cas
effector complexes have not been identified. Therefore, an
alternative scenario would derive the Class 1 effector
module from within the ancestral Casposon which, in this
case, would be postulated to have encoded a RRM-
domain nuclease.
The provenance of Class 2 effector modules is much
clearer [102, 103]. The type II and type V effectors (Cas9
and Cas12, respectively) appear to derive from the abun-
dant transposon genes known as tnpB which encode
nucleases with the RNase H fold (also often denoted
RuvC-like nucleases, after the homology to the bacterial
Holiday junction resolvase RuvC). The role of TnpB in
transposons remains unclear although it has been shown
that this protein is not required for transposition [104]. In
the Class 2 effectors, this nuclease cleaves the non-target
DNA strand whereas the target strand (the strand comple-
mentary to the crRNA) is cleaved by an additional nucle-
ase the identity of which differs between Cas9 and Cas12
[105, 106]. In the case of type CRISPR-Cas effector, Cas9,
a distinct family of TnpB homologs, denoted IscB, has
been identified as the direct ancestor as judged by high
level of sequence similarity and the presence of a HNH
inserted into the RuvC-like domain [107]. For the type V
effectors, the direct ancestors are harder to identify but
different subfamilies of TnpB appear to have given rise to
different subtypes as indicated by sequence similarity and
phylogenetic analysis [102, 103]. The type VI effectors,
Cas13, are unrelated to those in other CRISPR-Cas types
and contain two HEPN domains (Higher Eukaryotes and
Prokaryotes Nucleotide-Binding, an acronym coined at a
time when the actual activity of this domain was un-
known) which cleave RNA targets [108, 109]. As with type
V effectors, the exact ancestors of these proteins are diffi-
cult to pinpoint; either HEPN-domain containing Cas pro-
teins of Class 1 CRISPR-Cas systems, such as Csx6 and
Csn1, or HEPN-domain containing toxins could be impli-
cated [103]. The most plausible evolutionary scenario is
that Class 2 systems evolved when mobile elements
encoding ancestors of Class 2 effectors integrated near
orphan CRISPR arrays or displaced Class 1 effector
operons. Type II, type V and type VI systems, and most
likely, also different subtypes of type V apparently evolved
independently on several occasions given their evolu-
tionary affinity with different groups of TnpB or
HEPN-containing proteins. Thus, the history of Class 2
systems involved the second, after the Casposons,
major contribution of mobile elements to the evolution
of the CRISPR-Cas adaptive immunity.
There are striking parallels between the designs and the
likely evolutionary scenarios for the two best characterized
adaptive immunity systems, CRISPR-Cas in prokaryotes
and the protein-based adaptive immunity in jawed verte-
brates [101]. Both systems function by rearranging the
genome sequence, by inserting spacers into CRISPR arrays,
in the case of CRISPR-Cas, and recombining immuno-
globulin gene segments (VDJ recombination) in the case of
the vertebrate immune system. Both these processes are
mediated by recombinases derived from distinct, unrelated
transposons, Cas1 in the case of CRISPR-Cas, and the
Rag1-Rag2 recombinase in the vertebrate immune system.
Conceivably, both systems evolved as a result of insertion
of the respective, unrelated transposons next to an innate
immunity locus. The recent discovery of a family of trans-
posons that encode both Rag1, the catalytic subunit of the
recombinase, and Rag2, the accessory subunit, reinforces
this scenario [110]. A fundamental functional difference
between the prokaryotic and animal adaptive immunity sys-
tems is that the adaptation in the former is inherited across
generations whereas the vertebrate immunity only involves
genome rearrangement in somatic cells. The other major
difference is that, in the vertebrate immune system, target
recognition involves protein-protein interaction as opposed
to complementary interaction between nucleic acids.
Convergent evolution of the two nucleic acid-guided
defense systems of prokaryotes and their contrasting
fates in eukaryotes
As outlined above, there are two (currently known) dis-
tinct nucleic acid-guided forms of defense in archaea and
bacteria, the pAgo-centered innate immunity and the
CRISPR-Cas adaptive immunity. These two classes of
immune systems apparently evolved independently,
largely from unrelated protein domains (with the caveat
that the protein composition of the pAgo system is not
known in detail) (Table 1). There seems to be, however, a
degree of functional interaction between the two branches
of the guided defense. As a case in point, a subfamily of
pAgo genes are lodged within CRISPR-cas loci and
catalyze RNA-guided cleavage of ssDNA, presumably in
conjunction with CRISPR-Cas [111]. Conversely, it has
been shown that expression of pAgo in the presence of
the target plasmid stimulated also CRISPR-cas loci expres-
sion [112], suggesting that the innate and adaptive im-
mune system in bacteria could be functionally coupled.
The fates of the two major classes of prokaryotic nu-
cleic acid-guided defense systems in eukaryotes could
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not have been more different. The pAgo system was
directly inherited by the eukaryotes from the archaeal
ancestor and extensively elaborated during the evolution
of eukaryotes through the addition of extra components,
such as Dicer and RdRp, and serial duplication (Fig. 2).
The apparent assembly of the eukaryotic system from
three distinct prokaryotic sources, namely the archaeal
ancestry of eAgo and the helicase domain of Dicer, the
bacterial ancestry of the RNase III domains of Dicer and
the phage origin of the RdRp, emphasize the assignment
of the origin of RNAi to the stage of eukaryogenesis
[69]. At least under the symbiogenetic scenarios of
eukaryogenesis, this stage of evolution is envisaged as a
turbulent phase during which combination of genes of
different origins including gene fusion were common
and made diverse, substantial contributions to various
functional systems of eukaryotes [113–116]. In addition
to the dramatically increased complexity, the eukaryotic
eAgo-centered RNAi machinery was reprogrammed to
use RNA guides and to primarily target RNA. This
major switch of specificity was apparently precipitated
by the drastic change in the eukaryotic virosphere which
is dominated by RNA viruses, in a sharp contrast with
the DNA-dominated prokaryotic virome [117].
Unlike the pAgo-centered innate immunity, the CRISPR-
Cas adaptive immunity was not inherited by eukaryotes.
Strikingly, not only complete CRISPR-Cas systems but even
individual Cas proteins have no eukaryotic homologs (apart
from generic relationships among RRM domains, helicases
and some nucleases). How can we explain this conspicuous
absence of any traces of CRISPR-Cas in eukaryotes? One
possibility is “frozen accident” whereby neither the archaeal
host nor the bacterial endosymbiont that gave rise to
mitochondria possessed CRISPR-Cas. Such a “frozen
accident” cannot be ruled out because only a minority
of bacteria carry CRISPR-Cas, and some mesophilic
Table 1 The core proteins and domains comprising the RNA/DNA-guided immune systemsa
pAgo: innate immunity
in prokaryotes
Eukaryotic RNAi: innate immunity




NA NA Cas1: unique α-helical fold
Cas2: RRM
Guide RNA processing/maturation and amplification









Class2: [RNase III]; uncharacterized domains of effector proteins
Target recognition and cleavage
pAgo: RNase H, PAZ
additional nucleases(?)
eAgo: RNase H, PAZ Class 1: SF2 helicase, HD nuclease, PolB-like/RRM nuclease
Class 2: TnpB/RuvC (RNAse H fold), HEPN
aOnly the key, evolutionarily conserved domains are included for each system. The domains that are homologous between different classes of RNA/DNA-guided
systems are shown in bold type. For Class 2 CRISPR-Cas, RNase III is shown in brackets, to indicate that this is not a Cas protein
Fig. 2 The fates of prokaryotic defense systems in eukaryotes. C, CRISPR-Cas; RM, restriction-modification; TA, toxins-antitoxins
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archaea, apparently including Loki, lack these systems
as well [23].
However, there are also indications of biological causes
of the exclusion of CRISPR-Cas from eukaryotes. CRISPR-
Cas is not the only prokaryotic defense system that is
missing in eukaryotes: also absent are RM and TA
modules [118]. These defense systems share the key func-
tional feature of requiring both a toxin (the active moiety)
and an antitoxin, the regulatory moiety that prevents the
toxic effect [119, 120]. The toxin and antitoxin have to be
tightly co-regulated within the same operon, in order to
efficiently control the toxic effect. In TA systems, the anti-
toxin directly interacts with the toxin, whereas in the RM
systems, the modification component modifies the host
DNA, making it resistant to the restriction component.
Nevertheless, the general principle is the same for both
these types of defense systems and involves essential
coordination of expression and activity of the two
components. It seems likely that this principle applies
to CRISPR-Cas as well even though it is not a toxin-
antitoxin module per se. Several Cas protein contain
domains homologous to those in the common pro-
karyotic toxins including Cas2, which is a homolog of
the VapD family interferases, and also HEPN domain-
containing proteins (see above) [118]. Furthermore,
toxicity has been demonstrated for the Csa5 protein
although in this case, there are no homologs among
known toxins [121]. Most strikingly, the recently charac-
terized type VI CRISPR-Cas system appears to function as
a toxin through the promiscuous RNase activity of its
effector protein, Cas13a, which is induced by the recogni-
tion of the RNA target. Given that Cas13 proteins contain
two HEPN domains, which is one of the signatures of pro-
karyotic toxins, type VI systems seem to present a clear-
cut case of recruitment of toxins for functions in adaptive
immunity. Although much more experimentation re-
mains to be performed than had been done so far,
taken together, all these findings appear compatible
with the hypothesis on coupling between immunity
and programmed cell death/dormancy by CRISPR-Cas
systems [122–124]. Accordingly, the operon disrup-
tion ‘ratchet’ that was set into action by the emer-
gence of eukaryotes destroyed the coupling and
shifted the balance towards the toxic activity that
would be incompatible with the survival of the
eukaryotic cells [125]. Hence the rapid elimination of
the RM, TA and CRISPR-Cas loci at the onset of
eukaryotic evolution. Notably, however, the connec-
tion between RNAi and cell fate is likely to run deep
in eukaryotes as well as indicated by the recent
demonstration of the importance of RNAi for cell
quiescence, the eukaryotic counterpart to prokaryotic
dormancy [126].
Conclusion
The RNA/DNA-guided defense against genetic parasites
is based on, arguably, the most fundamental chemical
principle of life, nucleic acid complementarity, and
might have been the first defense strategy to evolve,
perhaps already in the primordial RNA world (Fig. 3).
Fig. 3 Evolution of RNA/DNA-guided defense and regulatory systems: from the RNA world to the present
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Archaea and bacteria possess two unrelated classes of
guided defense systems, the Argonaute-based innate im-
munity and CRISPR-Cas adaptive immunity. The fates
of these two defense systems in eukaryotes have been
opposite: CRISPR-Cas was completely lost, whereas the
Argonaute-based immune system underwent elaboration
and enormous diversification. This proliferation of the
Argonaute-based systems involved, in particular, the ori-
gin of the piRNA branch of RNAi that can be considered
a distinct form of adaptive immunity. The striking con-
trast between the fortunes of the two systems could be
due to the toxicity of certain Cas proteins that would be
unleashed in eukaryotes because of operon disruption.
In eukaryotes, numerous inactivated Argonautes
are recruited for regulatory roles, primarily in con-
junction with miRNA, and the same can be expected
to occur in prokaryotes although experimental data
are currently lacking. The CRISPR-Cas system also
assumed non-defense, regulatory functions in various
bacteria even as these remain understudied as well
[127]. The use of RNA or DNA guides for targeting
unique areas of the genome (or transcriptome) is the
most general possible strategy to achieve the goals of
defense, attack and regulation.
Apart from the two defense systems discussed above,
each of which also had been repeatedly recruited for
regulatory functions, there are several other molecular
machineries involved in natural genome engineering and
regulation. A striking case in point is the system of DNA
elimination during ciliate macronucleus development
that relies on the so called scanRNAs and leads to the
removal of varying fraction of the genome (up to more
the 90%) in different ciliates [19, 128]. Many of the re-
moved sequences originate from (largely inactive) trans-
posable elements, and therefore, these mechanisms, in a
sense, represent a distinct form of anti-parasite defense
[129]. Although not studied in comparable detail, it
appears most likely the DNA diminution that occurs
during the developments of certain animals, e.g.
Crustacea, employs analogous mechanisms [130]. A
widespread regulatory system that functions on the
RNA-guide principle is the prokaryotic small RNA regu-
lation [131]. Bacterial and archaeal genomes encode
from tens to hundreds small regulatory that in bacteria
function mostly as complexes with the RNA chaperone
Hfq [132]. This regulatory network is completely unre-
lated to either the Argonaute machinery or CRISPR-Cas.
The existence of yet other RNA-guided pathways is indi-
cated by the growing evidence of the major role of en-
dogenous antisense RNA in the regulation of gene
expression in eukaryotes [133, 134].
The universality of the central principle of RNA/DNA-
guided defense and regulation strongly suggests that sys-
tems functioning on this principle evolved on multiple
occasions in all forms of life. Even if the most common
of these systems are already known, identification of
new ones through combination of comparative genomics
and experimentation is a major research challenge.
Reviewers’ comments
Reviewer 1: Mikhail Gelfand, Research and Training
Center on Bioinformatics, A.A. Kharkevich Institute for
Information Transmission Problems, Russian Academy of
Sciences
This is a dual-purpose manuscript. Mainly it consists of
a precise and complete, as of today, review of prokary-
otic systems of nucleic acid (NA)-based immunity and
prokaryotic origins of eukaryotic systems. However, I
suspect that the real reason for writing this text has been
the hypothesis explaining why adaptive NA-based CRISPR-
Cas immunity has not been inherited by eukaryotes, unlike
RNA-interference mechanisms.
Author’s response: I appreciate the positive assessment
and to a large degree concur with the reviewer regarding
the incentive behind this manuscript. I would not go so
far as to say that this is the “real” reason but, indeed, the
main idea was to trace the dramatically different fates of
different eukaryotic defense systems in eukaryotes, and in
particular, to understand as best we can, why eukaryotes
lack CRISPR-Cas.
My marginal notes to the manuscript are mainly
crossed-over. This is because in many places, where I
had a suggestion or (so I thought) spotted an omission,
this had been addressed on the next page. The author
has not left out anything of importance; on the other
hand, this style leads to a lot of minor stresses – a reader
who has thought himself cleverer than the author is rou-
tinely disappointed. If this has not been the author’s
intention, maybe it would be better to explain “epigenetic
innate immunity” at the first occurrence (p.4, l.15-16),
mention VDJ recombination at the first discussion of
transposon contribution to adaptive immunity (p.11,
l.15-18), etc. The author’s hypothesis – eukaryotes could
not inherit systems that require tight co-regulation of com-
ponents due to disruption of operons – looks interesting.
However, there are a number of (admittedly minor) compli-
cations that need to be mentioned. Firstly, not all toxin-
antitoxin (TA) systems in prokaryotes are encoded in the
same operons; this is especially true for restriction-
modification (RM) systems. The components may reside
within one locus but in different operons, with correct
regulation provided by a cis-encoded transcription factor,
or even be distributed over the chromosome. (Here a pos-
sible explanation could be spatial separation of transcrip-
tion and translation, slowing the response.) Secondly, and
more generally, is tight co-regulation absolutely impossible
in eukaryotes? (Here one might note that even if this is pos-
sible in modern eukaryotes, it might be difficult in early,
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primitive eukaryotic cells.) Thirdly, some eukaryotes have
operons (likely of secondary origin, though). One of impli-
cations of the author’s theory is that other complexes or
systems whose individual components may be poisonous or
dangerous should (a) be encoded by operons in prokaryotes
and (b) should be lost in eukaryotes. This may be testable,
although requiring a lot of work. It looks like the situation
will not be clear-cut. For instance, intermediate products of
the riboflavin pathway are poisonous. In Firmicutes that en-
zymes forming the pathway are encoded by a single operon,
often tightly regulated by a riboswitch. However, in Proteo-
bacteria the genes are scattered, and often only one of then
seems to be regulated (again, by a riboswitch); what is really
surprising, this gene does not encode the enzyme respon-
sible for the first reaction, but a middle one: hence, if the
gene is repressed in conditions of abundant riboflavin, in-
termediates may still accumulate.
Author’s response: the author’s intent certainly has not
been to create “minor stresses” for the readers (even if one
could argue that this might work as an attention getter). I
considered the two specific suggestions made by the reviewer
and indeed added a more concrete explanation of “epigen-
etic innate immunity”. As for mentioning VDJ recombin-
ation in the beginning of the discussion of the contribution
of mobile elements to the evolution of defense systems, I do
not really agree. I think in this case, a small element of sus-
pense only helps, and the narrative comes to VDJ recombin-
ation exactly where it belongs. That said, the reviewer’s
comment prompted me to slightly expand the discussion of
the Rag1-Rag2 transposon and add a new reference. As for
other possible “minor stresses” (etc), I am afraid I cannot
easily identify those. Admittedly, this is likely to be an eas-
ier task for a reviewer/reader than for the author.
With regard to the exceptions from the co-regulation
“rule” for toxin-encoding functional systems, I certainly
appreciate these comments and expect them to be most
helpful for readers. That said, this is what these cases
are: (relatively) rare exceptions that emphasize the rele-
vance of the main rule. Ditto for tight co-regulation in
eukaryotes: it is not impossible but is much less common
and much harder to achieve than it is in prokaryotes.
The prediction that other complexes or systems containing
components that are dangerous in isolation should be tightly
co-regulated (mostly, by virtue of operons) and likely lost in
eukaryotes is pertinent and of major interest. I fully agree
with the reviewer that this is testable albeit not easy. Such a
project is underway, and hopefully, the findings that are
likely to be generally compatible with the prediction will be
published in a not so remote future.
I do not agree with the author’s statement that nucleo-
tide composition between plasmids and host chromosome
may be used for self/non-self discrimination (p.6, l.45-47)
– a protein (pAgo in this case) cannot measure the
nucleotide composition of a chromosome – how would it
collect statistical data? Moreover, nucleotide composition
of the chromosome also is not uniform, given recently
integrated mobile elements.
Author’s response: I agree, this was a weak proposition.
Dropped.
The statement that miRNA pathways do not involve
cleavage (p.7, l.2-29) seems to be too general: in mammals,
miRNA binding yields mRNA degradation.
Author’s response: This is about degradation by
other nucleases not Argonaute. I included a comment
to this effect.
At p.8, l.54-55 does the author imply that same fold
and same function equals homology?
Author’s response: “Equals” might not be the right word
here but the same fold does imply homology whereas the
same function does not. This is not the place for a general
discussion of this issue but the specific case of the RNA
polymerase is, I believe, appropriately addressed in the
cited references.
Reviewer 2: Bojan Zagrovic, Max F. Perutz Laboratories
(MFPL), Department of Structural and Computational
Biology, University of Vienna
The author presents a detailed, compelling and eloquent
chain of arguments concerning the evolution of DNA- and
RNA-guided immunity and, in particular, the evolutionary
connections between the prokaryotic pAgo-centered innate
immunity and CRISPR-Cas adaptive immunity on the one
hand and eukaryotic RNAi and its diverse variants on the
other. I find the discussion of the apparent lack of any
CRISPR-Cas-related mechanisms in eukaryotes as a par-
ticularly novel and exciting contribution, which is likely to
stimulate future discussion and work.
Author’s response: I appreciate these positive comments.
1. In an intriguing albeit speculative segment of the
text (P12-13), the author draws a parallel between the
organization and evolutionary developments of the
adaptive immunity strategies in prokaryotes and jawed
vertebrates. It would be interesting if the author
could extend and strengthen the line of argument
presented in this context. In particular, it may be in-
teresting to explore the differences and the similar-
ities between the two in relation to the fact that in
the former the recognition of foreign elements occurs
intra-cellularly, while in the latter it occurs extra-
cellularly. Perhaps the fact that the former system is
nucleic-acid-based and the latter protein-based may
be related in part to this very fact.
Author’s response: This is a perfectly salient and
interesting point. Given the Biology Direct format, I
believe that the comment will suffice to bring it to the
readers’ attention.
2. The author argues that the nucleic-acid complemen-
tarity is the most fundamental physico-chemical principle
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of life and that an RNA/DNA-guided defense system
based on it could have evolved already in the RNA world
context. Considering the recent results pointing at a possi-
bility of co-evolution and a high level of intertwining of
nucleic-acid and protein-based systems right from the
very beginnings of life (see, for example, the results
of Sutherland et al. who showed that chemical pre-
cursors of a number of nucleobases and amino acids
can be obtained via prebiotic synthetic routes [135])
or the results demonstrating the possibility of com-
plementary, specific interactions between nucleic acids
and proteins (e.g. [136], it may be interesting to con-
sider whether there are (were) any similar adaptive
immunity defense systems that are (were) based on
the direct recognition of nucleic acids and proteins
through direct, non-covalent interactions. In other
words, such recognition can also be thought of as a
potentially evolutionarily old physico-chemical
principle behind life and it would be interesting to
consider whether it has ever been utilized for the
purposes of differentiating between self and non-self
in the context of a separate defense system. While
there exist protein antibodies against nucleic acids
(which are especially important in the context of
autoimmune diseases), it is intriguing that the present
day systems involve predominantly either nucleic-
acid/nucleic-acid or protein/protein recognition.
Author’s response: Proteins and more so peptides indeed
could have been important components of (pre)biological
systems from the earliest stages of their evolution. However,
these must have been abiogenic or at least not nucleic
acid-encoded peptide as discussed at length in an earlier
paper [137]. Thus, it is difficult to imagine that these
molecules contributed to self vs non-self discrimination at
the earliest stages of evolution, whereas nucleic acids (most
likely, RNA) appear to be well suited for this role since the
very emergence of replication. As for the extant defense
systems, specific recognition of nucleic acids by pro-
teins is indeed widely utilized as demonstrated by
the RM mechanism.
1. In the title of the manuscript, it may be good to
reverse the positions of “RNA” and “DNA”, considering
the fact that the eukaryotes, which are named second,
preferentially used the RNA-based systems.
Author’s response: upon considering this suggestion, I
decided to stick with the original title given that overall,
RNA guides are much more common than DNA ones.
2. P3L26 should be “particles”. 3. P5L26 “the Ago
proteins” should be removed. 4. P8L12 it would be
good to explain what RISC stands for. 5. P16L41
“RNA” missing?
Author’s response: This is appreciated. Points 2–4 are
taken care of but I am unsure about point 5 because
there is no line 41 on p. 16.
Abbreviations
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